BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8131403)

  • 1. Suppression of graft rejection using 15-deoxyspergualin in the allogeneic rat penetrating keratoplasty model.
    Holland EJ; Olsen TW; Sterrer J; Ketchum JM; Mindrup EA; Gruber SA
    Cornea; 1994 Jan; 13(1):28-32. PubMed ID: 8131403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin inhibits corneal allograft rejection and neovascularization.
    Olsen TW; Benegas NM; Joplin AC; Evangelista T; Mindrup EA; Holland EJ
    Arch Ophthalmol; 1994 Nov; 112(11):1471-5. PubMed ID: 7980138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
    Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periocular FK-506 delays allograft rejection in rat penetrating keratoplasty.
    Dickey JB; Cassidy EM; Bouchard CS
    Cornea; 1993 May; 12(3):204-7. PubMed ID: 7684663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAD, a new immunosuppressive macrolide in murine corneal transplantation.
    Reis A; Megahed M; Reinhard T; Braunstein C; Godehardt E; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):689-92. PubMed ID: 11688669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental orthotopic penetrating keratoplasty--a rat penetrating keratoplasty model.
    Tchah H; Youn DH; Holland EJ
    J Korean Med Sci; 1991 Mar; 6(1):15-9. PubMed ID: 1888445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of donor-specific blood transfusion and a short course of deoxyspergualin in rat kidney transplantation.
    Tanabe K; Yasuo M; Nemoto K; Takahashi K; Toma H; Ota K
    Transpl Int; 1996; 9(4):353-8. PubMed ID: 8819269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.
    Minamoto A; Sakata H; Okada K; Fujihara M
    Jpn J Ophthalmol; 1995; 39(1):12-9. PubMed ID: 7543958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide therapy following penetrating keratoplasty in the rat.
    Coupland SE; Klebe S; Karow AC; Krause L; Kruse H; Bartlett RR; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):622-7. PubMed ID: 8001831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.
    Coupland SE; Krause L; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):116-24. PubMed ID: 8720682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
    Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
    Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model.
    Olsen TW; Gothard TW; Holland EJ
    Cornea; 1996 Jan; 15(1):76-81. PubMed ID: 8907385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
    Klebe S; Coupland SE; Krause L; Hoffmann F
    Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization interval and administration method alter the effect of 15-deoxyspergualin on heart transplantation in sensitized recipient rats.
    Ueda H; Itoh S; Iwamoto Y; Takasaki N
    Transpl Int; 1996; 9(6):551-6. PubMed ID: 8914234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation.
    Yamagami S; Tsuru T; Ohkawa T; Endo H; Isobe M
    Transplantation; 1999 Feb; 67(4):600-4. PubMed ID: 10071034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolase participation in allograft rejection in rat penetrating keratoplasty.
    Coupland S; Billson F; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):614-21. PubMed ID: 8001830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.